b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Data-Review" Owner="NLM">\n        <PMID Version="1">31934802</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>04</Month>\n            <Day>23</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1557-7732</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>36</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Apr</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</Title>\n                <ISOAbbreviation>J Ocul Pharmacol Ther</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>147-153</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1089/jop.2019.0087</ELocationID>\n            <Abstract>\n                <AbstractText><b>\n                        <i>Purpose:</i>\n                    </b> Dry eye disorders are a major health care burden. We previously reported the identification of <i>N</i>-methyl-<i>N</i>-phenyl-6-(2,2,3,3-tetrafluoropropoxy)-1,3,5-triazine-2,4-diamine [cystic fibrosis transmembrane conductance regulator (CFTR)<sub>act</sub>-K267], which activated human wild-type CFTR chloride conductance with EC<sub>50</sub> \xe2\x88\xbc 30\xe2\x80\x89nM. Here, we report <i>in vivo</i> evidence for CFTR<sub>act</sub>-K267 efficacy in an experimental mouse model of dry eye using a human compatible ophthalmic vehicle. <b>\n                        <i>Methods:</i>\n                    </b> CFTR activation in mice <i>in vivo</i> was demonstrated by ocular surface potential difference (OSPD) measurements. Ocular surface pharmacodynamics was measured in tear fluid samples obtained at different times after topical administration of CFTR<sub>act</sub>-K267. Dry eye was produced by lacrimal duct cautery (LDC) and corneal epithelial injury and was assessed by Lissamine green (LG) staining. <b>\n                        <i>Results:</i>\n                    </b> OSPD measurements demonstrated a hyperpolarization of -8.6\xe2\x80\x89\xc2\xb1\xe2\x80\x893\xe2\x80\x89mV (standard error of the mean, 5 mice) in response to CFTR<sub>act</sub>-K267 exposure in low chloride solution that was reversed by a CFTR inhibitor. Following single-dose topical administration of 2\xe2\x80\x89nmol CFTR<sub>act</sub>-K267, tear fluid CFTR<sub>act</sub>-K267 concentration was &gt;500\xe2\x80\x89nM for more than 6\xe2\x80\x89h. Following LDC, corneal surface epithelial injury, as assessed by LG staining, was substantially reversed in 10 of 12 eyes receiving 2\xe2\x80\x89nmol CFTR<sub>act</sub>-K267 3 times daily starting on day 2, when marked epithelial injury had already occurred. Improvement was seen in 3 of 12 vehicle-treated eyes. <b>\n                        <i>Conclusion:</i>\n                    </b> These studies provide <i>in vivo</i> evidence in mice for the efficacy of a topical, human use compatible CFTR<sub>act</sub>-K267 formulation in stimulating chloride secretion and reversing corneal epithelial injury in dry eye.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Chen</LastName>\n                    <ForeName>Xiaolan</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine and Physiology and University of California, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Jiangsu Agri-Animal Husbandry Vocational College, Taizhou, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lee</LastName>\n                    <ForeName>Sujin</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine and Physiology and University of California, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Tianyi</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine and Physiology and University of California, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Duan</LastName>\n                    <ForeName>Tianying</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine and Physiology and University of California, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pasricha</LastName>\n                    <ForeName>Neel D</ForeName>\n                    <Initials>ND</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ophthalmology, University of California, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schallhorn</LastName>\n                    <ForeName>Julie M</ForeName>\n                    <Initials>JM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ophthalmology, University of California, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Levin</LastName>\n                    <ForeName>Marc H</ForeName>\n                    <Initials>MH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Ophthalmology, Palo Alto Medical Foundation, Palo Alto, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Koprivica</LastName>\n                    <ForeName>Vuk</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Vanda Pharmaceuticals, Inc., Washington, District of Columbia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Verkman</LastName>\n                    <ForeName>Alan S</ForeName>\n                    <Initials>AS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine and Physiology and University of California, San Francisco, California.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>P30 DK072517</GrantID>\n                    <Acronym>DK</Acronym>\n                    <Agency>NIDDK NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>R01 DK101373</GrantID>\n                    <Acronym>DK</Acronym>\n                    <Agency>NIDDK NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>R01 EY013574</GrantID>\n                    <Acronym>EY</Acronym>\n                    <Agency>NEI NIH HHS</Agency>\n                    <Country>United States</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2020</Year>\n                <Month>01</Month>\n                <Day>14</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Ocul Pharmacol Ther</MedlineTA>\n            <NlmUniqueID>9511091</NlmUniqueID>\n            <ISSNLinking>1080-7683</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">CFTR</Keyword>\n            <Keyword MajorTopicYN="N">chloride channel</Keyword>\n            <Keyword MajorTopicYN="N">keratoconjunctivitis sicca</Keyword>\n            <Keyword MajorTopicYN="N">lacrimal duct cautery</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pmc-release">\n                <Year>2021</Year>\n                <Month>04</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31934802</ArticleId>\n            <ArticleId IdType="doi">10.1089/jop.2019.0087</ArticleId>\n            <ArticleId IdType="pmc">PMC7175624</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):54-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29305607</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Ophthalmol. 2019 Jun;202:47-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30721689</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Vis. 2013 Sep 19;19:1957-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24068863</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Doc Ophthalmol. 2003 Jan;106(1):43-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12675485</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cochrane Database Syst Rev. 2016 Feb 23;2:CD009729</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26905373</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Eye Res. 2002 Mar;24(3):182-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12221525</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Vis. 2011 Feb 15;17:469-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21365020</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ocul Surf. 2017 Jul;15(3):276-283</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28736335</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cornea. 2014 Dec;33(12):1336-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25255136</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Tissue Res. 2006 Jan;323(1):177-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16158324</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Immunol. 2017 Sep;182:55-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28476437</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Eye Res. 2010 Jun;90(6):771-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20346358</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FASEB J. 2016 May;30(5):1789-97</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26842854</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 1999 May;40(6):1261-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10235562</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Cell Physiol. 2002 Apr;282(4):C673-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11880256</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Med Chem. 2017 Feb 9;60(3):1210-1218</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28099811</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1428-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15790911</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Ophthalmol. 2019 Feb 01;13:225-232</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30774303</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cornea. 2018 Nov;37 Suppl 1:S58-S61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30211751</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Can J Physiol Pharmacol. 2002 Jun;80(6):533-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12117302</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Ophthalmol. 2015 May 15;9:865-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26028958</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Cell Physiol. 2005 Jan;288(1):C132-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15371258</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Discov Today. 2019 Aug;24(8):1427-1432</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30802601</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4506-4513</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28873176</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cornea. 2012 Mar;31(3):273-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22157573</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ocul Surf. 2017 Jul;15(3):575-628</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28736343</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Optom Vis Sci. 2015 Sep;92(9):e296-302</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26107023</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'